Member access

4-Traders Homepage  >  Shares  >  Tokyo  >  DAIICHI SANKYO COMPANY, LIMITED    4568   JP3475350009

SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 

DAIICHI S : Notice on Details of the Share Options

07/12/2011 | 05:20am US/Eastern
For Immediate Release

Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, President and CEO

(Code no.: 4568, First Section of Tokyo, Osaka and Nagoya Stock Exchanges) Please address inquiries to Toshiaki Sai, Corporate Officer, Vice President, Corporate Communications Department

Telephone: +81-3-6225-1126

http://www.daiichisankyo.com/Notice on Details of the Share OptionsTOKYO, Japan (July 12, 2011) Daiichi Sankyo Company, Limited has announced that the subscription amount and other details of its No.5 share options were decided today. As previously announced, the Board of Directors had reached a decision on June 27, 2011 to issue the said share remuneration-type stock options (share options) to remunerate Directors (excluding Outside Directors) and Corporate Officers

1. Name of share options

Daiichi Sankyo Company, Limited No. 5 share options

2. Total number of share options

2,328 share options (100 shares per one share option) Breakdown

Six (6) Directors: 1,102 share options

Eighteen (18) Corporate Officers: 1,226 share options

3. Subscription amount for share options

111,200 yen per share option

(1,112 yen per share)

Reference

Date of Board of Directors resolution: June 27, 2011

###
Latest news on DAIICHI SANKYO COMPANY, LI
1d ago RANBAXY LABORATORIES : posts 1st profit in 6 months
1d ago DAIICHI SANKYO : U.S. FDA Cardiovascular and Renal Drugs Advisory Committee Make..
1d ago DAIICHI SANKYO : Center for Connected Health Teamaing with Daiichi Sankyo
2d ago DAIICHI SANKYO : U.S. FDA Cardiovascular and Renal Drugs Advisory Committee Make..
2d ago Cipher Reports Financial Results for Q3 2014
2d ago Ranbaxy sees first profit in six qtrs on Diovan sales
2d ago RANBAXY TURNS AROUND, POSTS Rs478-CRORE PROFIT IN Q2
3d ago DAIICHI SANKYO : Health and Human Services Department (HHS); Food and Drug Admin..
3d ago RANBAXY LABORATORIES : Q2 FY 2015 Sales Rs.32,180 Mn. H1 FY2015 Sales Rs.55,902 ..
3d ago DAIICHI SANKYO : Center for Connected Health and Daiichi Sankyo, Inc. Sign Agree..
Advertisement
Chart
Duration : Period :
DAIICHI SANKYO COMPANY, LI Technical Analysis Chart | 4568 | JP3475350009 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF